|
Market Closed -
Nasdaq
00:00:00 31/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 4.110 USD | -2.84% |
|
-0.48% | +44.21% |
| 09-21 | Oramed Pharmaceuticals Inc.(NasdaqCM:ORMP) added to S&P Global BMI Index | CI |
| 09-01 | Lifeward Names Josh Hexter as Interim CEO and Rami Aviram as CFO | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ORMP | Delayed | |
CBOE
| ORMP | Real-time | |
|
TEL AVIV STOCK EXCHANGE
| ORMP | Delayed | |
|
Deutsche Boerse AG
| OJU1 | Delayed | |
|
Tradegate
| OJU1 | Real-time | |
|
Börse Stuttgart
| OJU1 | Delayed | |
|
Boerse Muenchen
| OJU1 | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Bullish |
| Resistance | 4.48 | 5.34 | 5.03 |
| Spread/Res. | -8.26% | -23.03% | -18.29% |
| Spread/Supp. | +1.23% | +14.17% | +10.78% |
| Support | 4.06 | 3.6 | 3.71 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ORMP Stock
- Charts Oramed Pharmaceuticals Inc.
Select your edition
All financial news and data tailored to specific country editions
